Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) Drug Interactions
A total of 1053 drugs (6151 brand and generic names) are known to interact with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine).
- 329 major drug interactions (1943 brand and generic names)
- 716 moderate drug interactions (4184 brand and generic names)
- 8 minor drug interactions (24 brand and generic names)
Check for interactions with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine)
Common medications checked in combination with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine)
- Aleve (naproxen)
- aluminum hydroxide / magnesium hydroxide / simethicone
- Aspir 81 (aspirin)
- Bactroban (mupirocin topical)
- KCl (potassium chloride)
- Lasix (furosemide)
- Levaquin (levofloxacin)
- metoprolol
- Tessalon Perles (benzonatate)
- Tobrex (tobramycin ophthalmic)
- Tylenol (acetaminophen)
- Zantac (ranitidine)
Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) alcohol/food Interactions
There are 2 alcohol/food interactions with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine)
Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) disease Interactions
There are 25 disease interactions with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) which include:
- Anticholinergic Effects
- Impaired Gi Motility
- Infectious Diarrhea
- Liver Disease
- Prematurity
- Renal Dysfunction
- Acute Alcohol Intoxication
- Drug Dependence
- Hypotension
- Intracranial Pressure
- Respiratory Depression
- Cardiovascular Disease
- Asthma/Copd
- Cardiovascular
- Renal/Liver Disease
- Adrenal Insufficiency
- Biliary Spasm
- Hypothyroidism
- Seizure Disorders
- Urinary Retention
- Arrhythmias
- Psychosis
- Bph
- Diabetes
- Glaucoma
Drug Interaction Classification
The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
